Does BIMEKIZUMAB Cause Inappropriate schedule of product administration? 238 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 238 reports of Inappropriate schedule of product administration have been filed in association with BIMEKIZUMAB (Bimzelx). This represents 9.7% of all adverse event reports for BIMEKIZUMAB.
238
Reports of Inappropriate schedule of product administration with BIMEKIZUMAB
9.7%
of all BIMEKIZUMAB reports
4
Deaths
56
Hospitalizations
How Dangerous Is Inappropriate schedule of product administration From BIMEKIZUMAB?
Of the 238 reports, 4 (1.7%) resulted in death, 56 (23.5%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Inappropriate schedule of product administration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIMEKIZUMAB. However, 238 reports have been filed with the FAERS database.
What Other Side Effects Does BIMEKIZUMAB Cause?
Psoriatic arthropathy (615)
Psoriasis (400)
Drug ineffective (293)
Injection site pain (225)
Product dose omission issue (163)
Off label use (160)
Oral candidiasis (146)
Fatigue (138)
Therapy interrupted (138)
Pneumonia (118)
What Other Drugs Cause Inappropriate schedule of product administration?
ADAPALENE (16,473)
DUPILUMAB (14,927)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (12,546)
INSULIN GLARGINE (8,982)
INFLIXIMAB (6,847)
INFLIXIMAB-DYYB (5,977)
SECUKINUMAB (4,817)
DULAGLUTIDE (3,606)
VEDOLIZUMAB (3,259)
SACUBITRIL\VALSARTAN (2,870)
Which BIMEKIZUMAB Alternatives Have Lower Inappropriate schedule of product administration Risk?
BIMEKIZUMAB vs BIMEKIZUMAB-BKZX
BIMEKIZUMAB vs BINIMETINIB
BIMEKIZUMAB vs BIOFLAVONOIDS
BIMEKIZUMAB vs BIOTIN
BIMEKIZUMAB vs BIPERIDEN